International Assets Investment Management LLC Acquires New Holdings in Encompass Health Co. (NYSE:EHC)

International Assets Investment Management LLC acquired a new position in Encompass Health Co. (NYSE:EHC) in the fourth quarter, Holdings Channel reports. The fund acquired 30,296 shares of the company’s stock, valued at approximately $20,210,000.

A number of other hedge funds also recently bought and sold shares of the stock. Nordea Investment Management AB lifted its stake in shares of Encompass Health by 21.0% during the 4th quarter. Nordea Investment Management AB now owns 101,705 shares of the company’s stock worth $6,787,000 after purchasing an additional 17,684 shares during the last quarter. Oak Thistle LLC lifted its position in shares of Encompass Health by 19.1% during the fourth quarter. Oak Thistle LLC now owns 14,436 shares of the company’s stock valued at $963,000 after buying an additional 2,319 shares during the last quarter. Sei Investments Co. grew its position in shares of Encompass Health by 6.7% in the 3rd quarter. Sei Investments Co. now owns 306,796 shares of the company’s stock worth $20,604,000 after buying an additional 19,254 shares during the last quarter. FMR LLC raised its stake in shares of Encompass Health by 11.6% during the 3rd quarter. FMR LLC now owns 1,374,755 shares of the company’s stock worth $92,329,000 after acquiring an additional 142,633 shares in the last quarter. Finally, Oppenheimer & Co. Inc. lifted its position in Encompass Health by 10.7% during the third quarter. Oppenheimer & Co. Inc. now owns 113,501 shares of the company’s stock valued at $7,623,000 after acquiring an additional 10,958 shares during the last quarter. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Insiders Place Their Bets

In other news, CEO Mark J. Tarr sold 44,976 shares of the company’s stock in a transaction dated Tuesday, April 30th. The stock was sold at an average price of $83.27, for a total value of $3,745,151.52. Following the sale, the chief executive officer now owns 554,098 shares in the company, valued at $46,139,740.46. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 2.10% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

EHC has been the topic of several analyst reports. Barclays lifted their price target on shares of Encompass Health from $101.00 to $108.00 and gave the stock an “overweight” rating in a report on Thursday, April 25th. William Blair reaffirmed an “outperform” rating on shares of Encompass Health in a research report on Wednesday, February 7th. Mizuho raised their price target on Encompass Health from $93.00 to $95.00 and gave the stock a “buy” rating in a report on Thursday, April 25th. Truist Financial boosted their price target on Encompass Health from $82.00 to $86.00 and gave the stock a “buy” rating in a research note on Friday, February 9th. Finally, Raymond James reaffirmed a “strong-buy” rating and issued a $95.00 price objective (up from $85.00) on shares of Encompass Health in a research report on Friday, April 26th. Eight analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, Encompass Health presently has an average rating of “Buy” and a consensus target price of $90.29.

Encompass Health Stock Down 0.3 %

Shares of EHC stock opened at $83.21 on Friday. The company has a debt-to-equity ratio of 1.14, a quick ratio of 1.28 and a current ratio of 1.37. Encompass Health Co. has a fifty-two week low of $57.55 and a fifty-two week high of $85.84. The firm has a market capitalization of $8.33 billion, a PE ratio of 22.49, a P/E/G ratio of 1.30 and a beta of 0.92. The stock’s 50-day simple moving average is $79.15 and its 200-day simple moving average is $71.55.

Encompass Health (NYSE:EHC) last issued its quarterly earnings results on Wednesday, April 24th. The company reported $1.12 earnings per share for the quarter, topping the consensus estimate of $0.93 by $0.19. Encompass Health had a net margin of 7.60% and a return on equity of 18.01%. The company had revenue of $1.32 billion for the quarter, compared to the consensus estimate of $1.27 billion. Encompass Health’s quarterly revenue was up 13.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.88 EPS. Equities analysts expect that Encompass Health Co. will post 4.1 earnings per share for the current year.

Encompass Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, July 15th. Shareholders of record on Monday, July 1st will be issued a $0.15 dividend. This represents a $0.60 annualized dividend and a yield of 0.72%. The ex-dividend date is Friday, June 28th. Encompass Health’s payout ratio is 16.22%.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.